Cara Therapeutics | CARA - هزینه PE به سود





Pe تغییر دادن تاریخ
Acadia Pharmaceuticals 11.61 2.09 2025-12
Cara Therapeutics 27.77 117.09 2021-09
Chugai Pharma 31.26 5.24 2025-12
Cipla 27.74 3.55 2025-12
Clal Biotechnology 11.67 2.62 2022-12
Compugen 4.06 75.75 2025-12
CSL 16.16 9.59 2025-12
Grifols 11.2 1.08 2025-12
Halozyme Therapeutics 23.16 7.7 2025-12
J&J 23.62 0.86 2025-12
Neurocrine Biosciences 835.47 802.2 2025-12
Pacira 52.68 23.44 2025-12
Pfizer 14.48 5.18 2025-12
RedHill Biopharma 0.04 0.03 2025-06
Supernus Pharmaceuticals 110.38 71.27 2025-12
Vanda Pharmaceuticals 16.79 7.07 2023-06